Investor insights
Sectors invested in
Funding rounds participated in
$1M sweet spot round size
Most of their 51 investments are in rounds between $10M and $40M
Investor type
Basic info
Industry
Sectors
Date founded
2005
Investments made
PIC Therapeutics raised $35M on October 19, 2022
Investors: Lumira Ventures, OrbiMed Advisors, Harrington Discovery Institute at University Hospitals and Advent Life Sciences
Tridek-One raised $16M on September 15, 2022
Investors: Pureos Bioventures, Bioqube Ventures, AdBio partners and Advent Life Sciences
Moximed raised $40M on August 16, 2022
Investors: Morgenthaler, GBS Venture Partners, Future Fund, Gilde Healthcare and Advent Life Sciences
MiroBio Ltd raised $97M on June 29, 2022
Investors: Monograph Capital, Oxford Sciences Innovation, OrbiMed Advisors, Samsara BioCapital, S.R. One Ltd, Medicxi and Advent Life Sciences
Wondr Medical raised $15M on June 28, 2022
Investors: Sonder Capital and Advent Life Sciences
Epitopea raised $13M on April 25, 2022
Investors: Novateur Ventures Inc., Cambridge Innovation Capital plc, Harrington Discovery Institute at University Hospitals and Advent Life Sciences
Nalu Medical, Inc. raised $104M on February 17, 2022
Investors: Gilde Healthcare, Aperture Venture Partners, Decheng Capital, Pura Vida Investments, Longitude Capital, MVM Partners, Endeavour Vision and Advent Life Sciences
AviadoBio raised $78M on December 2, 2021
Investors: Monograph Capital, EQT Life Sciences, F-Prime Capital Partners, The Dementia Discovery Fund and Advent Life Sciences
NERRE THERAPEUTICS LTD raised $28M on July 7, 2021
Investors: COLUMBUS VENTURE PARTNERS,S.G.E.I.C., S.A.U., OrbiMed Advisors, Forbion and Advent Life Sciences
Aura Biosciences raised $80M on March 22, 2021
Investors: COLUMBUS VENTURE PARTNERS,S.G.E.I.C., S.A.U., Chiesi Ventures, Lundbeckfonden / Lundbeck Foundation, Arix Bioscience plc, Ysios Capital, Surveyor Capital, Medicxi and Advent Life Sciences